IDEXX Laboratories, Inc.'s Investors Look the Gift Horse in the Mouth
IDEXX Laboratories (NASDAQ: IDXX) reported solid revenue growth with operating income and earnings growing even faster allowing the animal diagnostic company to raise 2017 guidance.
But investors looked the gift horse in the mouth and sent shares down 7% on Tuesday, presumably because short-term thinkers believed guidance should have been raised even more.
Metric
Source: Fool.com
Idexx Laboratories Inc. Stock
€435.70
0.350%
Idexx Laboratories Inc. is currently one of the favorites of our community with 13 Buy predictions and no Sell predictions.
As a result the target price of 550 € shows a positive potential of 26.23% compared to the current price of 435.7 € for Idexx Laboratories Inc..